We have observed
8 EP applications
Axel Bernhard Berger
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Stable crystalline monohydrate of epirubicin hydrochloride and method of production
BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF CANCER THERAPY
METHOD FOR THE SYNTHESIS OF RAPAMYCIN DERIVATIVES
METHOD FOR THE SYNTHESIS OF PENTOSTATIN
METHOD FOR THE SYNTHESIS OF CLOFARABINE
EZH2 INHIBITORS AND MODULATION OF REGULATORY T-CELL FUNCTION